| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NITE | Nightstar Therapeutics plc | Whitcup Scott M | Director | Jun 07, 2019 | Option Exercise | $25.50 | 74,568 | 1,901,484 | 0 | Jun 07, 2019, 04:41 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Feb 20, 2015 | Option Exercise | $234.00 | 80 | 18,720 | 17,175 | Feb 24, 2015, 09:48 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Feb 14, 2014 | Option Exercise | $124.57 | 284 | 35,378 | 17,043 | Feb 19, 2014, 02:45 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Jan 14, 2014 | Sale | $86.89 | 84,000 | 7,298,550 | 59,327 | Jan 15, 2014, 06:24 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Jan 08, 2014 | Sale | $84.89 | 84,000 | 7,130,550 | 59,327 | Jan 10, 2014, 06:37 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Jan 03, 2014 | Option Exercise | $73.98 | 48,400 | 3,580,390 | 41,527 | Jan 07, 2014, 05:08 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Dec 20, 2013 | Sale | $108.80 | 33,000 | 3,590,400 | 17,327 | Jan 06, 2014, 06:27 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Dec 20, 2013 | Option Exercise | $72.48 | 66,000 | 4,783,350 | 33,827 | Dec 20, 2013, 07:41 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Apr 11, 2013 | Option Exercise | $75.58 | 24,010 | 1,814,556 | 29,332 | Apr 15, 2013, 04:00 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Apr 03, 2013 | Option Exercise | $75.58 | 26,390 | 1,994,424 | 30,522 | Apr 05, 2013, 05:05 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Apr 01, 2013 | Option Exercise | $76.47 | 16,000 | 1,223,544 | 25,327 | Apr 02, 2013, 02:37 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Mar 26, 2013 | Option Exercise | $74.08 | 22,968 | 1,701,355 | 28,811 | Mar 27, 2013, 07:11 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Mar 21, 2013 | Option Exercise | $74.08 | 2,382 | 176,447 | 18,518 | Mar 25, 2013, 06:41 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Mar 25, 2013 | Option Exercise | $74.08 | 9,850 | 729,639 | 22,252 | Mar 25, 2013, 06:41 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Feb 20, 2013 | Option Exercise | $108.08 | 5,218 | 563,961 | 17,327 | Feb 22, 2013, 07:17 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Feb 15, 2013 | Option Exercise | $108.02 | 434 | 46,881 | 22,545 | Feb 20, 2013, 08:30 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Jan 04, 2013 | Sale | $69.02 | 48,000 | 3,312,960 | 46,979 | Jan 07, 2013, 07:16 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Dec 07, 2012 | Sale | $60.68 | 13,600 | 825,241 | 29,779 | Dec 11, 2012, 07:50 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Oct 17, 2012 | Sale | $62.41 | 10,000 | 624,125 | 27,979 | Oct 18, 2012, 05:12 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Oct 01, 2012 | Sale | $61.41 | 12,000 | 736,950 | 28,979 | Oct 02, 2012, 08:11 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | May 30, 2012 | Sale | $60.42 | 3,000 | 181,249 | 24,479 | May 31, 2012, 06:35 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | May 16, 2012 | Sale | $61.06 | 3,000 | 183,188 | 24,479 | May 18, 2012, 02:55 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Feb 22, 2012 | Option Exercise | $87.27 | 45 | 3,927 | 22,979 | Feb 24, 2012, 06:40 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Feb 14, 2012 | Option Exercise | $88.11 | 1,470 | 129,514 | 22,480 | Feb 16, 2012, 07:13 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | May 18, 2011 | Option Exercise | $56.41 | 11,000 | 620,460 | 29,450 | May 19, 2011, 02:36 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | May 11, 2011 | Sale | $80.85 | 608 | 49,156 | 23,950 | May 12, 2011, 08:05 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | May 04, 2011 | Sale | $54.86 | 4,000 | 219,440 | 26,558 | May 05, 2011, 08:15 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Feb 17, 2011 | Sale | $75.72 | 4,000 | 302,891 | 23,728 | Feb 18, 2011, 05:30 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Dec 14, 2010 | Option Exercise | $54.78 | 30,040 | 1,645,740 | 42,748 | Dec 15, 2010, 06:24 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Dec 01, 2010 | Option Exercise | $53.62 | 14,800 | 793,503 | 35,128 | Dec 02, 2010, 06:49 PM |
Menu